Here's the recent articles submitted by curex bio
Articles By curex bio
How Accurate Clinical Documentation Speeds Regulatory Approvals
Submitted as: curex
CurexBio emphasizes the importance of precise clinical documentation for regulatory compliance. Operating as a reputable CRO in India, the USA, and Canada, we offers extensive services aimed at ensuring meticulous document preparation to meet standards.(read
entire article)
View : 83 Times
Category : Business
The Role Of Cro Services In Oral Solid Dosage (osd) Development
Submitted as: curex
CurexBio's Regulatory Affairs team has expertise in major entities like the FDA, EMA, DCGI, and NMPA, offering support from pre-submission to IND and NDA submissions.(read
entire article)
View : 476 Times
Category : General
How Clinical Research Supports Successful Generic Drug Launches
Submitted as: curex
Accurate data collection and management are essential for successful submissions, with CurexBio assisting sponsors in ensuring data integrity, database validation, query management, data cleaning, and regulatory compliance.(read
entire article)
View : 73 Times
Category : General
Clinical Development Services For Generic Pharmaceuticals
Submitted as: curex
Regulatory obligations persist post-product approval. CurexBio provides pharmacovigilance services to assist manufacturers in maintaining compliance through adverse event processing, signal detection, aggregate reporting, risk management, and safety surveillance.(read
entire article)
View : 89 Times
Category : General
Clinical Trial Requirements For Generic Tablet And Capsule Manufacturers
Submitted as: curex
Data Integrity: Regulatory inspections are emphasizing data integrity practices, with the FDA's April 2024 guidance detailing expectations for data integrity in in vivo bioavailability and bioequivalence studies. All clinical trial studies initiated after December 17, 2016, must submit data in CDISC-compliant format.(read
entire article)
View : 87 Times
Category : General
Bioequivalence Studies: A Critical Step For Generic Tablet Approval
Submitted as: curex
CurexBio aids in regulatory strategy development, submission preparation, gap assessments, agency response management, and lifecycle maintenance.(read
entire article)
View : 65 Times
Category : General
Top 10 Bioanalytical Challenges That Delay Drug Development
Submitted as: curex
Whether you are developing a small molecule, biologic, biosimilar, vaccine, or next-generation therapy, CurexBio provides end-to-end bioanalytical support tailored to your program's unique requirements.(read
entire article)
View : 78 Times
Category : General
Common Documentation Errors In Generic Drug Submissions
Submitted as: curex
CurexBio manages clinical operations including site selection, training, and regulatory file maintenance, ensuring trials comply with GCP standards from the start, thus establishing a reliable foundation for the final report(read
entire article)
View : 44 Times
Category : General
Choosing The Right Clinical Research Partner For Global Clinical Trials
Submitted as: curex
Early engagement and shared decision-making between partners lead to improved communication and accountability, resulting in more consistent teams throughout a study. This approach significantly affects problem resolution speed, as timely reporting of issues by partners mitigates risks effectively.(read
entire article)
View : 41 Times
Category : General
Clinical Development Challenges In Tablet And Capsule Manufacturing
Submitted as: curex
Changes in formulation or manufacturing during development may necessitate bridging studies or bioequivalence work, potentially resetting timelines and increasing costs if not managed properly.(read
entire article)
View : 39 Times
Category : General
